In addition, because Treg cells express CTLA-4, the anti-CTLA-4 antibody can regulate Treg cells in the tumor microenvironment and induce iRAEs by abolishing the inhibitory function of Tregs (60). The gene discussed is CTLA4; the disease is neoplasm.